Search Results - "Timillero, L."

Prevalence and Risk Factors for Nosocomial Infections in Hospitals of the Veneto Region, North-Eastern Italy by Pellizzer, G., Mantoan, P., Timillero, L., Allegranzi, B., Fedeli, U., Schievano, E., Benedetti, P., Saia, M., Sax, H., Spolaore, P.

“…Objective: The study aimed to assess prevalence and risk factors for nosocomial infection (NI) in 21 hospitals of the Veneto Region (Italy). Methods: In May…”
Get full text

Linkage of microbiology reports and hospital discharge diagnoses for surveillance of surgical site infections by Spolaore, P., Pellizzer, G., Fedeli, U., Schievano, E., Mantoan, P., Timillero, L., Saia, M.

“…Surveillance of surgical site infections (SSIs) with feedback to surgical personnel is pivotal in decisions regarding infection control. Prospective…”
Get full text

093 OUTPATIENT PARENTERAL ANTIBIOTIC THERAPY FOR INFECTIVE ENDOCARDITIS. SINGLE-CENTRE EXPERIENCE by Carlotto, A, Ferretto, R, Timillero, L, Rossi, L, Esposito, S, Marranconi, F

Get full text

Predictors of protease inhibitor-associated adverse events by Bonfanti, P., Ricci, E., Landonio, S., Valsecchi, L., Timillero, L., Faggion, I., Quirino, T.

“…Risk factors in the development of adverse reactions in HIV-1-infected patients treated with highly active antiretroviral therapy (HAART) containing protease…”
Get full text

Incidence of adverse reactions in HIV patients treated with protease inhibitors : A Cohort Study by BONFANTI, P, VALSECCHI, L, DI CINTIO, E, MARTINELLI, C, FAGGION, I, LANDONIO, S, QUIRINO, T, PARAZZINI, F, CARRADORI, S, PUSTERLA, L, FORTUNA, P, TIMILLERO, L, ALESSI, F, GHISELLI, G, GABBUTI, A

“…To assess the probability that protease inhibitor (PI) therapy might be discontinued because of adverse events (AE) and to evaluate the incidence rate of…”
Get full text

Regional and systemic prophylaxis with teicoplanin in total knee arthroplasty A tissue penetration study by Lazzarini, Luca, Novelli, Andrea, Marzano, Nicola, Timillero, Lia, Fallani, Stefania, Viola, Renato, de Lalla, Fausto

“…Five patients undergoing total knee arthroplasty (TKA) received 800 mg intravenous teicoplanin systemically 2.5 hours before surgery and 15 patients received…”
Get full text

Risk factors for lipodystrophy in the CISAI cohort by Bonfanti, Paolo, Gulisano, Cecilia, Ricci, Elena, Timillero, Lia, Valsecchi, Laura, Carradori, Silvia, Pusterla, Luigi, Fortuna, Paolo, Miccolis, Sebastiano, Magnani, Carlo, Gabbuti, Andrea, Parazzini, Fabio, Martinelli, Canio, Faggion, Ivano, Landonio, Simona, Quirino, Tiziana, Vigevani, GianMarco

“…Purpose. – This study set out to describe the frequency of lipodystrophy, and identify its risk factors, in HIV-positive patients treated with HAART containing…”
Get full text

Predictors of protease inhibitor-associated adverse events : AIDS by BONFANTI, P, RICCI, E, LANDONIO, S, VALSECCHI, L, TIMILLERO, L, FAGGION, I, QUIRINO, T

Get full text

Incidence of adverse reactions in HIV patients treated with protease inhibitors: a cohort study. Coordinamento Italiano Studio Allergia e Infezione da HIV (CISAI) Group by Bonfanti, P, Valsecchi, L, Parazzini, F, Carradori, S, Pusterla, L, Fortuna, P, Timillero, L, Alessi, F, Ghiselli, G, Gabbuti, A, Di Cintio, E, Martinelli, C, Faggion, I, Landonio, S, Quirino, T

“…To assess the probability that protease inhibitor (PI) therapy might be discontinued because of adverse events (AE) and to evaluate the incidence rate of…”
Get full text

Causality relationship of drug adverse reactions: experience in the use of HIV-protease inhibitors by Bonfanti, P, Valsecchi, L, Parazzini, F, Carradori, S, Pusterla, L, Fortuna, P, Timillero, L, Alessi, F, Ghiselli, G, Gabbuti, A, Ricci, E, Martinelli, C, Faggion, I, Landonio, S, Quirino, T

“…To establish the exact cause and effect relationship between protease inhibitors (PIs) and adverse events. Prospective, cohort, multicenter study on…”
Get more information